Publication | Open Access

Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England

Glucose-lowering TherapiesDiabetes ManagementPreventive MedicineDiabetes EpidemiologyHealth PolicyGlobal HealthDiabetesNationwide Observational StudyType 2Diabetes MellitusPublic HealthMedicineCovid-19